PED/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells

Human Gene Therapy

Volumn 21, Issue 9, 2010, Pages 1067-1076

  Botta, Ginevra ^a   Perruolo, Giuseppe ^a,b   Libertini, Silvana ^a   Cassese, Angela ^a,b   Abagnale, Antonella ^a   Beguinot, Francesco ^a   Formisano, Pietro ^a   Portella, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOLYTIC ADENOVIRUS; PHOSPHOPROTEIN; PHOSPHOPROTEIN ENRICHED IN DIABETES PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; EMBRYO; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GLIOMA CELL; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; ONCOLYTIC VIROTHERAPY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VIRUS ENTRY; VIRUS INFECTION; VIRUS INFECTIVITY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; CELL DEATH; CELL LINE, TUMOR; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RECEPTORS, VIRUS; TRANSFECTION;

ADENOVIRIDAE; COXSACKIEVIRUS;

EID: 77957833597     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.181     Document Type: Article

References (41)

1. Anders, M., Christian, C., McMahon, M., McCormick, F., and Korn, W.M. (2003). Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res. 63, 2088-2095.
2. Argyriou, A.A., Antonacopoulou, A., Iconomou, G., and Kalo-fonos, H.P. (2009). Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies. Crit. Rev. Oncol. Hematol. 69, 199-210.
3. Arnberg, N. (2009). Adenovirus receptors: Implications for tropism, treatment and targeting. Rev. Med. Virol. 19, 165-178.
4. Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L., and Finberg, R.W. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
5. Brandes, A.A., Tosoni, A., Franceschi, E., Reni, M., Gatta, G., and Vecht, C. (2008). Glioblastoma in adults. Crit. Rev. Oncol. Hematol. 67, 139-152.
6. Cohen, C.J., Shieh, J.T., Pickles, R.J., Okegawa, T., Hsieh, J.T., and Bergelson, J.M. (2001). The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. U.S.A. 98, 15191-15196.
7. Condorelli, G., Vigliotta, G., Iavarone, C., Caruso, M., Tocchetti, C.G., Andreozzi, F., Cafieri, A., Tecce, M.F., Formisano, P., Beguinot, L., and Beguinot, F. (1998). PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 17, 3858-3866.
8. Condorelli, G., Trencia, A., Vigliotta, G., Perfetti, A., Goglia, U., Cassese, A., Musti, A.M., Miele, C., Santopietro, S., Formisano, P., and Beguinot, F. (2002). Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J. Biol. Chem. 277, 11013-11018.
9. Coyne, C.B., and Bergelson, J.M. (2005). CAR: A virus receptor within the tight junction. Adv. Drug Deliv. Rev. 57, 869-882.
10. Eckert, A., Böck, B.C., Tagscherer, K.E., Haas, T.L., Grund, K., Sykora, J., Herold-Mende, C., Ehemann, V., Hollstein, M., Chneiweiss, H., Wiestler, O.D., Walczak, H., and Roth, W. (2008). The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene 27, 1155-1166.
11. v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6, 1520-1535.
12. Formstecher, E., Ramos, J.W., Fauquet, M., Calderwood, D.A., Hsieh, J.C., Canton, B., Nguyen, X.T., Barnier, J.V., Camonis, J., Ginsberg, M.H., and Chneiweiss, H. (2001). PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1, 239-250.
13. Furnari, F.B., Fenton, T., Bachoo, R.M., Mukasa, A., Stommel, J.M., Stegh, A., Hahn, W.C., Ligon, K.L., Louis, D.N., Brennan, C., Chin, L., DePinho, R.A., and Cavenee, W.K. (2007. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev. 21, 2683-2710.
14. Fuxe, J., Liu, L., Malin, S., Philipson, L., Collins, V.P., and Pet-tersson, R.F. (2003). Expression of the coxsackie and adeno-virus receptor in human astrocytic tumors and xenografts. Int. J. Cancer 103, 723-729.
15. Garofalo, M., Romano, G., Quintavalle, C., Romano, M.F., Chiurazzi, F., Zanca, C., and Condorelli, G. (2007). Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int. J. Cancer 120, 1215-1222.
16. Hao, C., Beguinot, F., Condorelli, G., Trencia, A., Van Meir, E.G., Yong, V.W., Parney, I.F., Roa, W.H., and Petruk, K.C. (2001). Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res. 61, 1162-1170.
17. Haseley, A., Alvarez-Breckenridge, C., Chaudhury, A.R., and Kaur, B. (2009). Advances in oncolytic virus therapy for gli-oma. Recent Pat. CNS Drug Discov. 4, 1-13.
18. Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., and Kirn, D. (2000). An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6, 1134-1139.
19. Hill, J.M., Vaidyanathan, H., Ramos, J.W., Ginsberg, M.H., and Werner, M.H. (2002). Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 21, 6494-6504.
20. Hsu, K.L., Lonberg-Holm, K., Alstein, B., and Crowell, R.L. (1988). A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol. 62, 1647-1652.
21. Jiang, H., Gomez-Manzano, C., Aoki, H., Alonso, M.M., Kondo, S., McCormick, F., Xu, J., Kondo, Y., Bekele, B.N., Colman, H., Lang, F.F., and Fueyo, J. (2007). Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic cell death. J. Natl. Cancer Inst. 99, 1410-1414.
22. Libertini, S., Iacuzzo, I., Ferraro, A., Vitale, M., Bifulco, M., Fusco, A., and Portella, G. (2007). Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its anti-neoplastic activity against anaplastic thyroid carcinoma cells. Endocrinology 148, 5186-5194.
23. Nemerow, G.R. (2000). Cell receptors involved in adenovirus entry. Virology 274, 1-4.
24. Portella, G., Scala, S., Vitagliano, D., Vecchio, G., and Fusco, A. (2002). ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 8, 2525-2531.
25. Rein, D.T., Breidenbach, M., and Curiel, D.T. (2006). Current developments in adenovirus-based cancer gene therapy. Future Oncol. 2, 137-143.
26. Renault, F., Formstecher, E., Callebaut, I., Junier, M.P., and Chneiweiss, H. (2003). The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astro-cytes. Biochem. Pharmacol. 66, 1581-1588.
27. Renganathan, H., Vaidyanathan, H., Knapinska, A., and Ramos, J.W. (2005). Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem. J. 390, 729-735.
28. Ruvolo, P.P., Deng, X., Carr, B.K., and May, W.S. (1998). A functional role for mitochondrial protein kinase Ca in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273, 25436-25442.
29. Sharif, A., Renault, F., Beuvon, F., Castellanos, R., Canton, B., Barbeito, L., Junier, M.P., and Chneiweiss, H. (2004). The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 126, 263-275.
30. Sherr, C.J. (2000). The Pezcoller Lecture: Cancer cell cycle revisited. Cancer Res. 60, 3689-3695.
31. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112.
32. INK4b in glioblastoma multiforme. Cancer Res. 68, 8657-8660.
33. Song, J.H., Bellail, A., Tse, M.C., Yong, V.W., and Hao, C. (2006). Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apo-ptosis. J. Neurosci. 26, 3299-3308.
34. Stassi, G., Garofalo, M., Zerilli, M., Ricci-Vitiani, L., Zanca, C., Todaro, M., Aragona, F., Limite, G., Petrella, G., and Con-dorelli, G. (2005). PED mediates AKT-dependent chemoresis-tance in human breast cancer cells. Cancer Res. 65, 6668-6675.
35. Tomko, R.P., Johansson, C.B., Totrov, M., Abagyan, R., Frisén, J., and Philipson, L. (2000). Expression of the adenovirus receptor and its interaction with the fiber knob. Exp. Cell Res. 255, 47-55.
36. Vähä-Koskela, M.J., Heikkilä, J.E., and Hinkkanen, A.E. (2007). Oncolytic viruses in cancer therapy. Cancer Lett. 254, 178-216.
37. Vecil, G.G., and Lang, F.F. (2003). Clinical trials of adenoviruses in brain tumors: A review of Ad-p53 and oncolytic adeno-viruses. J. Neurooncol. 65, 237-246.
38. Watanabe, T., Hioki, M., Fujiwara, T., Nishizaki, M., Kagawa, S., Taki, M., Kishimoto, H., Endo, Y., Urata, Y., Tanaka, N., and Fujiwara, T. (2006). Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Exp. Cell Res. 312, 256-265.
39. Whitehurst, A.W., Robinson, F.L., Moore, M.S., and Cobb, M.H. (2004). The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J. Biol. Chem. 279, 12840-12847.
40. Xiao, C., Yang, B.F., Asadi, N., Beguinot, F., and Hao, C. (2002). Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 277, 25020-25025.
41. Zanca, C., Garofalo, M., Quintavalle, C., Romano, G., Acunzo, M., Ragno, P., Montuori, N., Incoronato, M., Tornillo, L., Baum-hoer, D., Briguori, C., Terracciano, L., and Condorelli, G. (2008). PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J. Cell. Mol. Med. 12, 2416-2426.